BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8865907)

  • 21. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
    Liu YL; Kao MT; Huang CC
    Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carrier-status for nasal staphylococci does not predict infections in CAPD patients.
    Lubrich-Birkner I; Schollmeyer P; Böhler J
    Adv Perit Dial; 1994; 10():154-7. PubMed ID: 7999816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis peritonitis.
    Coles GA; Alobaidi HM; Topley N; Davies M
    Nephrol Dial Transplant; 1987; 2(5):359-65. PubMed ID: 3122114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of positive dialysate cultures after apparent cure of CAPD peritonitis.
    Tzamaloukas AH; Hartshorne MF; Gibel LJ; Murata GH
    Adv Perit Dial; 1993; 9():198-201. PubMed ID: 8105923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritonitis prevention in continuous ambulatory peritoneal dialysis.
    Luzar MA
    Nephrologie; 1992; 13(4):171-7. PubMed ID: 1407258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
    Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
    Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical complications of Tenckhoff catheters used in continuous ambulatory peritoneal dialysis.
    Tiong HY; Poh J; Sunderaraj K; Wu YJ; Consigliere DT
    Singapore Med J; 2006 Aug; 47(8):707-11. PubMed ID: 16865213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of infection rates among older and younger patients on continuous peritoneal dialysis.
    Holley JL; Bernardini J; Perlmutter JA; Piraino B
    Perit Dial Int; 1994; 14(1):66-9. PubMed ID: 8312418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu-erythropoietin?
    Selgas R; Castro MJ; Bajo MA; Fernandez-Reyes MJ; Lopez-Revuelta K; Romero JR; de Alvaro F; Borrego F; Riñon C
    Adv Perit Dial; 1992; 8():253-7. PubMed ID: 1361800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and cause of removal of peritoneal dialysis catheter in patients on continuous ambulatory peritoneal dialysis.
    Nodaira Y; Ikeda N; Kobayashi K; Watanabe Y; Inoue T; Gen S; Kanno Y; Nakamoto H; Suzuki H
    Adv Perit Dial; 2008; 24():65-8. PubMed ID: 18986004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients.
    Cavdar C; Sayan M; Sifil A; Artuk C; Yilmaz N; Bahar H; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):71-6. PubMed ID: 12745749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Staphylococcus aureus colonization and risk of developing a subsequent peritonitis episode caused by an identical strain, among pediatric patients admitted for continuous ambulatory peritoneal dialysis].
    Miranda-Novales G; Aburto y-Huesca R; Leaños-Miranda B; Mendoza-Guevara L; Paniagua R; Amato D
    Gac Med Mex; 2008; 144(4):297-302. PubMed ID: 18942263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in infections with the introduction of mupirocin cream at the peritoneal dialysis catheter exit site.
    Uttley L; Vardhan A; Mahajan S; Smart B; Hutchison A; Gokal R
    J Nephrol; 2004; 17(2):242-5. PubMed ID: 15293524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The outcome of peritonitis in patients on automated peritoneal dialysis.
    Yishak A; Bernardini J; Fried L; Piraino B
    Adv Perit Dial; 2001; 17():205-8. PubMed ID: 11510277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics and outcome of peritoneal dialysate leaks and associated infections.
    Holley JL; Bernardini J; Piraino B
    Adv Perit Dial; 1993; 9():240-3. PubMed ID: 8105934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002).
    Kavanagh D; Prescott GJ; Mactier RA
    Nephrol Dial Transplant; 2004 Oct; 19(10):2584-91. PubMed ID: 15304559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A ten-year single-centre experience in children on chronic peritoneal dialysis--significance of percutaneous placement of peritoneal dialysis catheters.
    Aksu N; Yavascan O; Anil M; Kara OD; Erdogan H; Bal A
    Nephrol Dial Transplant; 2007 Jul; 22(7):2045-51. PubMed ID: 17438008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.
    Chuang YW; Shu KH; Yu TM; Cheng CH; Chen CH
    Nephrol Dial Transplant; 2009 May; 24(5):1603-8. PubMed ID: 19103738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.